| Financial Year |
March 31 2023 |
| Monetary Funds |
820,876,231.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
10,445,831.26 |
| Accounts Receivable |
321,881,057.05 |
| Advances to Suppliers |
8,740,093.54 |
| Other Receivables |
684,546.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
73,537,859.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,652,358.87 |
| Total Current Assets |
1,296,890,081.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,165,988,589.22 |
| Under-construction Projects |
112,163,388.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,843,537.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
965,491.66 |
| Deferred Income Tax Assets |
30,858,907.83 |
| Other Non-Current Assets |
8,760,317.01 |
| Sub-Total of Non-Current Assets |
1,405,687,938.79 |
| Total Assets |
2,702,578,020.51 |
| Short-Term Loans |
5,004,791.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,311,173.18 |
| Accounts Payable |
152,640,505.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,021,796.63 |
| Taxes Payable |
7,300,488.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
258,708.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,008,459.07 |
| Other Current Liabilities |
56,609.31 |
| Sub-Total of Current Liabilities |
270,037,988.57 |
| Long-term Loans |
241,421,698.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
298,984,898.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
484,556.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
566,998,654.74 |
| Total Liabilities |
837,036,643.31 |
| Paid-In Capital(Or Share Stock) |
296,644,037.00 |
| Capital Surplus |
806,091,528.77 |
| Surplus Reserve |
64,074,860.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
493,525,662.11 |
| Minority Stockholder's Interest |
205,205,288.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,660,336,088.58 |
| Owner's Equity（Stockholder's Equity） |
1,865,541,377.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,702,578,020.51 |
